Danaher and Zhen'en Biotech Jointly Establish Danaher China Western Center in Chongqing

ShanghaiNovember 8, 2023PR Newswire -- November 7, 2023, at the 6th China International Import Expo, Danaher announced the establishment of the Danaher Western China Center in Chongqing with ZEIN BIOTECHNOLOGY CO., LTD., leveraging the leading and chain-leading role of enterprises to promote innovation and development in the regional biopharmaceuticals industry.

Danaher Partners with ZEIN BIOTECHNOLOGY CO., LTD. to Build Danaher Western China Center in Chongqing

Under the guidance of the "14th Five-Year Plan for Pharmaceutical Industry Development" and the "Chongqing Municipal Biomedical Industry 14th Five-Year Plan," Danaher Corporation and ZEIN BIOTECHNOLOGY CO., LTD. have joined forces to collaboratively establish the "Danaher Western China Center."

Both parties will leverage their respective industry advantages to jointly integrate high-quality resources in Southwest China. They will introduce functions such as life science laboratories and venture capital funds in phases, and host influential biotechnology training sessions and market exchange summits. This collaboration aims to form an innovative platform that integrates technology research and development, talent training, project incubation, and fund investment. The Danaher Western China Center will apply the Danaher Business System (DBS) to collaborate with industry peers in exploring business growth, lean management, leadership, and other modules to promote the development of the pharmaceuticals industry.

Both parties will focus on empowering the Chengdu-Chongqing economic belt and the pharmaceutical R&D of western China with the "Danaher Western China Center" as the core. A scientific, open, and shared R&D, production, and testing platform will be established to attract a large number of supply chain enterprises, build a high-quality closed-loop industrial chain, promote the "three-chain integration" of the industry chain, innovation chain, and service chain, and establish an industrial cluster marked by medical diagnostics, biologics, and precision therapies.